SCHEMBL31060403

SCHEMBL31060403

COc1cccc(OCc2cccc(-c3ccccc3)c2C)n1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 19/20 0.57
PDCD1 Q15116 6/20 0.55
NT5E P21589 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22401056 0.85 CD274 (0.55) CD274PDCD1
SCHEMBL20763871 0.82 CD274 (0.63) CD274PDCD1NT5E
SCHEMBL16555129 0.81 CD274 (0.61) CD274PDCD1NT5E
SCHEMBL19788562 0.79 CD274 (0.70) CD274PDCD1
SCHEMBL29271887 0.79 CD274 (0.63) CD274PDCD1
SCHEMBL17898328 0.78 CD274 (0.65) CD274PDCD1
SCHEMBL24822011 0.78 CD274 (0.61) CD274PDCD1
SCHEMBL16554533 0.77 CD274 (0.67) CD274PDCD1
SCHEMBL23495003 0.77 CD274 (0.49) CD274PDCD1
SCHEMBL24822304 0.77 CD274 (0.67) CD274PDCD1NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed